-
Product Insights
Dyspnea Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Dyspnea Global Clinical Trials Review, H1, 2019" provides an overview of Dyspnea clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspnea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Emphysema Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Emphysema Global Clinical Trials Review, H1, 2019" provides an overview of Emphysema clinical trials scenario. This report provides top line data relating to the clinical trials on Emphysema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Empyema Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Empyema Global Clinical Trials Review, H1, 2019" provides an overview of Empyema clinical trials scenario. This report provides top line data relating to the clinical trials on Empyema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Chronic Cough Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Chronic Cough Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Cough clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Cough. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Chronic Obstructive Pulmonary Disease (COPD) Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Obstructive Pulmonary Disease (COPD) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Obstructive Pulmonary Disease (COPD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Chronic Respiratory Failure Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Chronic Respiratory Failure Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Respiratory Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Respiratory Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Croup Disease - Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Croup Global Clinical Trials Review, H1, 2019" provides an overview of Croup clinical trials scenario. This report provides top line data relating to the clinical trials on Croup. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
Asthma and Chronic Obstructive Pulmonary Disease - Asthma ahead of COPD in terms of Innovation with the Focus on Targeted Biologic Therapies for Severe Disease Phenotypes
Asthma and COPD are both highly prevalent, chronic, inflammatory diseases of the airways and lungs. The asthma market is highly saturated with relatively efficacious standard therapies and the COPD market is also highly saturated with therapies that help to prevent exacerbations of the disease. However, there is considerable unmet need for innovative new therapies for severe asthmatics who do not respond to the current standards of care, and treatments which can reverse the progression of COPD. This report assesses first-in-class...
-
Sector Analysis
Allergic Rhinitis - Epidemiology Forecast to 2028
Allergic rhinitis (AR) is a chronic inflammatory condition of the nasal mucosa, caused by immunoglobulin E (IgE)-mediated early-phase and late-phase hypersensitivity responses (Scadding, 2015). AR symptoms include rhinorrhea, nasal obstruction and blockage, nasal itching, and repetitive sneezing (Scadding, 2015; National Health Services, 2019). It is being increasingly recognized that if AR is poorly managed, it can have a major impact on quality of life, emotional well-being, sleep, daily activities, and productivity. AR is also associated with considerable economic burden (Linneberg...
-
Sector Analysis
Cystic Fibrosis (CF) - Epidemiology Forecast to 2030
Cystic fibrosis (CF) is a progressive, inherited disorder that primarily affects the respiratory and digestive systems. In people with CF, mucus, sweat, and other fluids produced in these systems are sticky and thick, and may obstruct the passageways in the lungs and pancreas (Mayo Clinic, 2021). Mucus build-up and airway blockages in the lungs cause symptoms such as persistent cough, wheezing, inflamed nasal passages, and recurrent lung infections. Impacts on the digestive system can lead to chronic constipation, intestinal blockages,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.